Charles River Laboratories International (CRL) Liabilities and Shareholders Equity (2009 - 2026)
Charles River Laboratories International (CRL) posted Liabilities and Shareholders Equity of $7.53 billion for Q2 2026, down 0.4% from $7.56 billion a year earlier and down 2.6% from the prior quarter.
Powered by 
Analysis
Charles River Laboratories International (CRL) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Charles River Laboratories International's Liabilities and Shareholders Equity came in at $7.14 billion, down 5.2% from FY2024.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
- In prior years, Charles River Laboratories International's Liabilities and Shareholders Equity was $7.53 billion in FY2024 (-8.1%), $8.2 billion in FY2023 (+7.8%), $7.6 billion in FY2022 (+8.2%) and $7.02 billion in FY2021 (+27.9%).
- Quarterly Liabilities and Shareholders Equity has run from a low of $7.02 billion in Q4 2021 to a high of $8.2 billion in Q4 2023 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in two of the last eight quarters, with an average decline of 3.1%.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2021, with growth of 27.9%; the weakest was Q4 2024, with a decline of 8.1%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $7.73 billion (Q1 2026), $7.14 billion (Q4 2025) and $7.51 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 43.61 Bn | 35.31 Bn | 1.44 Bn | 29.88 Bn |
| 2 | Medpace Holdings | 17.32 Bn | 15.38 Bn | 201.64 Mn | 2.06 Bn |
| 3 | Charles River Laboratories International | 14.52 Bn | 13.72 Bn | 363.37 Mn | 7.53 Bn |
| 4 | Icon | 13.20 Bn | 10.31 Bn | 479.29 Mn | 16.40 Bn |
| 5 | Fortrea Holdings | 2.04 Bn | 1.42 Bn | 139.20 Mn | 2.71 Bn |
| 6 | Ginkgo Bioworks Holdings | 725.88 Mn | -36.20 Mn | 18.44 Mn | 990.05 Mn |
| 7 | Evotec SE | 509.65 Mn | -1.10 Bn | - | 1.80 Bn |
| 8 | Champions Oncology | 67.26 Mn | 42.35 Mn | 7.70 Mn | 33.29 Mn |
| 9 | MindWalk Holdings | 65.40 Mn | 29.05 Mn | 1.61 Mn | 12.36 Mn |
| 10 | Natural Alternatives International | 6.69 Mn | -21.39 Mn | 1.73 Mn | 126.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 7.53 Bn |
| Mar 28, 2026 | 7.73 Bn |
| Dec 27, 2025 | 7.14 Bn |
| Sep 27, 2025 | 7.51 Bn |
| Jun 28, 2025 | 7.56 Bn |
| Mar 29, 2025 | 7.58 Bn |
| Dec 28, 2024 | 7.53 Bn |
| Sep 28, 2024 | 8.00 Bn |
| Jun 29, 2024 | 7.95 Bn |
| Mar 30, 2024 | 8.15 Bn |
| Dec 30, 2023 | 8.20 Bn |
| Sep 30, 2023 | 7.61 Bn |
| Jul 1, 2023 | 7.77 Bn |
| Apr 1, 2023 | 7.70 Bn |
| Dec 31, 2022 | 7.60 Bn |
| Sep 24, 2022 | 7.38 Bn |
| Jun 25, 2022 | 7.53 Bn |
| Mar 26, 2022 | 7.08 Bn |
| Dec 25, 2021 | 7.02 Bn |
| Sep 25, 2021 | 7.06 Bn |
API Access
Charles River Laboratories International Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CRL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();